Thursday, December 08, 2016 12:07:19 PM
With respect to the rest of your thoughts --
"status of development, update on projected timelines, funding strategies and budget vs. burn rate, any progress on the regulatory front (CE and/or FDA), marketing plans, and imminent publicity we can look forward to. + also mention that to those of us who believe in this technology, the few times it has had any public exposure, we are proud of the instrument and the organization and always excited to hear feedback from those who saw it in person"
-- I think asking for an update at the start of the New Year would be appropriate. I would also reiterate that "we are always anxious to learn of any progress" and especially any contact between Titan and the outside world. Barker et al are surely making an effort, after all they're trying to save their asses! We don't want to be unreasonable but we want to be kept in the loop.
Truly do appreciate your contribution. JMO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM